The historical rank and industry rank for Exact Sciences's FCF Margin % or its related term are showing as below:
EXAS'
s FCF Margin % Range Over the Past 10 Years
Min: -5197.39 Med: -40.32 Max: 4.79
Current: 1.28
During the past 13 years, the highest FCF Margin % of Exact Sciences was 4.79%. The lowest was -5197.39%. And the median was -40.32%.
EXAS's FCF Margin % is ranked better than 62.95% of 224
companies
in the Medical Diagnostics & Research industry
Industry Median: -10.51
vs EXAS: 1.28
Exact Sciences FCF Margin % Historical Data
The historical data trend for Exact Sciences's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Exact Sciences's FCF Margin %
For the Diagnostics & Research subindustry, Exact Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Exact Sciences's FCF Margin % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Exact Sciences's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Exact Sciences's FCF Margin % falls into.
Exact Sciences FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Exact Sciences's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Exact Sciences FCF Margin % Related Terms
Thank you for viewing the detailed overview of Exact Sciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Exact Sciences (Exact Sciences) Business Description
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EXAS has been successfully added to your 